AR SCR11

Encourages U.S. Congress and the FDA to enter international reciprocity agreements that would automatically approve medications already approved in countries with similar pharmaceutical regulatory systems, such as the United Kingdom.

Argues that such agreements could provide Americans access to potentially life-saving medications currently unavailable in the U.S. and create alternatives for drugs in shortage.

Notes the U.S. accounts for more than one-third of the global pharmaceutical market and cites the FDA's stringent, costly, and lengthy drug approval process as a barrier to medication access.

Aligns with the spirit of Arkansas's Right to Try Act (§ 20-15-2101 et seq.), which permits terminal illness patients to access investigational drugs, biological products, and devices.

Requires the Secretary of the Senate to send copies of the resolution to the FDA, U.S. Senate majority leader, House Speaker, and Arkansas congressional delegation upon adoption.